# EDGAR Filing Document

**Accession Number:** 0000088048
**File Stem:** 0001410368-26-040953
**Filing Date:** 2026-4
**Character Count:** 37183
**Document Hash:** 4844637ce32e682b76a852d3aeee8462
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-26-040953.hdr.sgml**: 20260427

**ACCESSION NUMBER**: 0001410368-26-040953

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260228

**FILED AS OF DATE**: 20260427

**DATE AS OF CHANGE**: 20260427

**PERIOD START**: 20260531

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DEUTSCHE DWS SECURITIES TRUST
- **CENTRAL INDEX KEY:** 0000088048

**ORGANIZATION NAME:**
- **EIN:** 132661231
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-02021
- **FILM NUMBER:** 26900718

**BUSINESS ADDRESS:**
- **STREET 1:** 875 THIRD AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022-6225
- **BUSINESS PHONE:** 212-454-4500

**MAIL ADDRESS:**
- **STREET 1:** 875 THIRD AVENUE
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022-6225

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DEUTSCHE SECURITIES TRUST
- **DATE OF NAME CHANGE:** 20140811

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DWS SECURITIES TRUST
- **DATE OF NAME CHANGE:** 20060207

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SCUDDER SECURITIES TRUST
- **DATE OF NAME CHANGE:** 19950908

## Series and Classes Contracts Data

### DWS Health and Wellness Fund (Series ID: S000006103)

| Class ID   | Class Name          | Ticker Symbol   |
|:---|:---|:---|
| C000016782 | Class A             | SUHAX           |
| C000016785 | Class C             | SUHCX           |
| C000016786 | Class S             | SCHLX           |
| C000016787 | Institutional Class | SUHIX           |

## Nport-Ex

Investment Portfolio**as of February 28, 2026 (Unaudited)** 

**DWS Health and Wellness Fund** 

---

| | | |
|:---|:---|:---|
|  | **Shares** | **Value ($)** |
| **Common Stocks 99.8%** | **Common Stocks 99.8%** |  |
| **Health Care 99.8%** | **Health Care 99.8%** |  |
| **Biotechnology 19.7%** | **Biotechnology 19.7%** |  |
| AbbVie, Inc.  | 52180 | &nbsp;&nbsp; 12109934 |
| Alnylam Pharmaceuticals, Inc.\*  | 7001 | &nbsp;&nbsp; 2330773 |
| Amgen, Inc.  | 19793 | &nbsp;&nbsp; 7682851 |
| Apellis Pharmaceuticals, Inc.\*  | 3200 | &nbsp;&nbsp; 67072 |
| Argenx SE (ADR)\*  | 2823 | &nbsp;&nbsp; 2165015 |
| Biogen, Inc.\*  | 11150 | &nbsp;&nbsp; 2138793 |
| BioMarin Pharmaceutical, Inc.\*  | 14842 | &nbsp;&nbsp; 916197 |
| Gilead Sciences, Inc.  | 47850 | &nbsp;&nbsp; 7127258 |
| Incyte Corp.\*  | 12579 | &nbsp;&nbsp; 1273875 |
| Insmed, Inc.\*  | 8239 | &nbsp;&nbsp; 1230330 |
| Natera, Inc.\*  | 4500 | &nbsp;&nbsp; 936180 |
| Neurocrine Biosciences, Inc.\*  | 11537 | &nbsp;&nbsp; 1525768 |
| Regeneron Pharmaceuticals, Inc.  | 5885 | &nbsp;&nbsp; 4600128 |
| Vertex Pharmaceuticals, Inc.\*  | 13581 | &nbsp;&nbsp; 6747448 |
|  |  | &nbsp;&nbsp; **50851622** |
| **Health Care Distributors 5.7%** | **Health Care Distributors 5.7%** |  |
| Cardinal Health, Inc.  | 16900 | &nbsp;&nbsp; 3873987 |
| Cencora, Inc.  | 10814 | &nbsp;&nbsp; 4024322 |
| McKesson Corp.  | 6900 | &nbsp;&nbsp; 6812853 |
|  |  | &nbsp;&nbsp; **14711162** |
| **Health Care Equipment 19.2%** | **Health Care Equipment 19.2%** |  |
| Abbott Laboratories  | 64801 | &nbsp;&nbsp; 7539596 |
| Baxter International, Inc.  | 27600 | &nbsp;&nbsp; 562212 |
| Becton Dickinson & Co.  | 12200 | &nbsp;&nbsp; 2153056 |
| Boston Scientific Corp.\*  | 100856 | &nbsp;&nbsp; 7750784 |
| Dexcom, Inc.\*  | 24708 | &nbsp;&nbsp; 1814308 |
| Edwards Lifesciences Corp.\*  | 21596 | &nbsp;&nbsp; 1867406 |
| GE HealthCare Technologies, Inc.  | 19500 | &nbsp;&nbsp; 1643265 |
| Globus Medical, Inc. "A"\*  | 8100 | &nbsp;&nbsp; 773226 |
| IDEXX Laboratories, Inc.\*  | 3089 | &nbsp;&nbsp; 2028639 |
| Insulet Corp.\*  | 5332 | &nbsp;&nbsp; 1314925 |
| Intuitive Surgical, Inc.\*  | 14659 | &nbsp;&nbsp; 7380953 |
| Medtronic PLC  | 48488 | &nbsp;&nbsp; 4735338 |
| ResMed, Inc.  | 9347 | &nbsp;&nbsp; 2395262 |
| Stryker Corp.  | 19804 | &nbsp;&nbsp; 7673258 |
|  |  | &nbsp;&nbsp; **49632228** |
| **Health Care Services 1.4%** | **Health Care Services 1.4%** |  |
| Labcorp Holdings, Inc.  | 3490 | &nbsp;&nbsp; 1009029 |
| Privia Health Group, Inc.\*  | 41332 | &nbsp;&nbsp; 981635 |
| RadNet, Inc.\*  | 24997 | &nbsp;&nbsp; 1745040 |
|  |  | &nbsp;&nbsp; **3735704** |
| **Health Care Supplies 1.7%** | **Health Care Supplies 1.7%** |  |
| Alcon AG  | 30597 | &nbsp;&nbsp; 2667447 |

---

------

---

| | | |
|:---|:---|:---|
| EssilorLuxottica SA  | 3400 | &nbsp;&nbsp; 898093 |
| The Cooper Companies, Inc.\*  | 10700 | &nbsp;&nbsp; 895269 |
|  |  | &nbsp;&nbsp; **4460809** |
| **Health Care Technology 0.4%** | **Health Care Technology 0.4%** |  |
| Veeva Systems, Inc.A\*  | 5218 | &nbsp;&nbsp; **949728** |
| **Life Sciences Tools & Services 8.9%** | **Life Sciences Tools & Services 8.9%** |  |
| Agilent Technologies, Inc.  | 19806 | &nbsp;&nbsp; 2404052 |
| Bio-Techne Corp.  | 9200 | &nbsp;&nbsp; 542800 |
| Danaher Corp.  | 28238 | &nbsp;&nbsp; 5948052 |
| Illumina, Inc.\*  | 4691 | &nbsp;&nbsp; 630752 |
| IQVIA Holdings, Inc.\*  | 11400 | &nbsp;&nbsp; 2038434 |
| Repligen Corp.\*  | 3200 | &nbsp;&nbsp; 411936 |
| Thermo Fisher Scientific, Inc.  | 16298 | &nbsp;&nbsp; 8493051 |
| Waters Corp.\*  | 4191 | &nbsp;&nbsp; 1338522 |
| West Pharmaceutical Services, Inc.  | 5015 | &nbsp;&nbsp; 1275515 |
|  |  | &nbsp;&nbsp; **23083114** |
| **Managed Health Care 5.4%** | **Managed Health Care 5.4%** |  |
| Centene Corp.\*  | 21174 | &nbsp;&nbsp; 950289 |
| Humana, Inc.  | 3116 | &nbsp;&nbsp; 593723 |
| UnitedHealth Group, Inc.  | 42323 | &nbsp;&nbsp; 12412066 |
|  |  | &nbsp;&nbsp; **13956078** |
| **Pharmaceuticals 37.4%** | **Pharmaceuticals 37.4%** |  |
| AstraZeneca PLC (ADR)  | 47473 | &nbsp;&nbsp; 9895747 |
| Bristol-Myers Squibb Co.  | 60816 | &nbsp;&nbsp; 3793094 |
| Eli Lilly & Co.  | 31554 | &nbsp;&nbsp; 33194492 |
| EyePoint, Inc.\*  | 21900 | &nbsp;&nbsp; 384564 |
| Johnson & Johnson  | 63685 | &nbsp;&nbsp; 15821265 |
| Merck & Co., Inc.  | 94719 | &nbsp;&nbsp; 11728107 |
| Novartis AG (ADR)  | 44700 | &nbsp;&nbsp; 7537314 |
| Novo Nordisk A/S (ADR)  | 88210 | &nbsp;&nbsp; 3303464 |
| Pfizer, Inc.  | 103470 | &nbsp;&nbsp; 2860946 |
| Roche Holding AG (Genusschein)  | 5700 | &nbsp;&nbsp; 2695676 |
| Sandoz Group AG (ADR)  | 8200 | &nbsp;&nbsp; 721764 |
| Sanofi SA (ADR)  | 38050 | &nbsp;&nbsp; 1851513 |
| Zoetis, Inc.  | 21656 | &nbsp;&nbsp; 2839102 |
|  |  | &nbsp;&nbsp; **96627048** |
| **Total Common Stocks** (Cost $94,342,862) |  | &nbsp;&nbsp; **258007493** |
| **Cash Equivalents 0.4%** | **Cash Equivalents 0.4%** |  |
| DWS Central Cash Management Government Fund, 3.68% (a) (Cost $1,127,879) | 1127879 | &nbsp;&nbsp; **1127879** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
|  | **% of** <br>**Net Assets**<br>| **Value ($)** |
| **Total Investment Portfolio** (Cost $95,470,741) | 100.2 | &nbsp;&nbsp; **259135372** |
| **Other Assets and Liabilities, Net** | (0.2)<br>| &nbsp;&nbsp; **(479812)**<br>|
| **Net Assets** | 100.0 | &nbsp;&nbsp; **258655560** |

---

*For information on the Fund's policies regarding the valuation of investments and other significant accounting policies, please refer to the Fund's most recent semi-annual or annual financial statements.*

------

*A summary of the Fund's transactions with affiliated investments during the period ended February 28, 2026 are as follows:* 

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Value ($) at** <br>**5/31/2025**<br>| &nbsp;&nbsp; **Purchases** <br>**Cost ($)**<br>| &nbsp;&nbsp; **Sales** <br>**Proceeds ($)**<br>| &nbsp;&nbsp; **Net Realized** <br>**Gain/** <br>**(Loss) ($)**<br>| &nbsp;&nbsp; **Net Change in** <br>**Unrealized** <br>**Appreciation** <br>**(Depreciation) ($)**<br>| **Income ($)** | &nbsp;&nbsp; **Capital Gain** <br>**Distributions ($)**<br>| &nbsp;&nbsp; **Number** <br>**of Shares** <br>**at** <br>**2/28/2026**<br>| &nbsp;&nbsp; **Value ($) at** <br>**2/28/2026**<br>|
| **Securities Lending Collateral 0.0%** | **Securities Lending Collateral 0.0%** | **Securities Lending Collateral 0.0%** | **Securities Lending Collateral 0.0%** | **Securities Lending Collateral 0.0%** | **Securities Lending Collateral 0.0%** | **Securities Lending Collateral 0.0%** | **Securities Lending Collateral 0.0%** | **Securities Lending Collateral 0.0%** |
| DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", <br>3.57% (a) (b) | DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", <br>3.57% (a) (b) | DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", <br>3.57% (a) (b) | DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", <br>3.57% (a) (b) | DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", <br>3.57% (a) (b) | DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", <br>3.57% (a) (b) | DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", <br>3.57% (a) (b) | DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", <br>3.57% (a) (b) | DWS Government & Agency Securities Portfolio "DWS Government Cash Institutional Shares", <br>3.57% (a) (b) |
| 2532775  | —  | 2,532,775 (c) | —  | —  | 2215  | —  | —  | —  |
| **Cash Equivalents 0.4%** | **Cash Equivalents 0.4%** | **Cash Equivalents 0.4%** | **Cash Equivalents 0.4%** | **Cash Equivalents 0.4%** | **Cash Equivalents 0.4%** | **Cash Equivalents 0.4%** | **Cash Equivalents 0.4%** | **Cash Equivalents 0.4%** |
| DWS Central Cash Management Government Fund, 3.68% (a) | DWS Central Cash Management Government Fund, 3.68% (a) | DWS Central Cash Management Government Fund, 3.68% (a) | DWS Central Cash Management Government Fund, 3.68% (a) | DWS Central Cash Management Government Fund, 3.68% (a) | DWS Central Cash Management Government Fund, 3.68% (a) | DWS Central Cash Management Government Fund, 3.68% (a) | DWS Central Cash Management Government Fund, 3.68% (a) | DWS Central Cash Management Government Fund, 3.68% (a) |
| 722182  | 32879763  | 32474066  | —  | —  | 70603  | —  | 1127879  | 1127879  |
| **3254957** | **32879763** | **35006841** | **—** | **—** | **72818** | **—** | **1127879** | **1127879** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*\** *Non-income producing security.* 

*(a)* *Affiliated fund managed by DWS Investment Management Americas, Inc. The rate shown is the annualized seven-day yield at* *period end.* 

*(b)* *Represents cash collateral held in connection with securities lending. Income earned by the Fund is net of borrower rebates.*

*(c)* *Represents the net increase (purchase cost) or decrease (sales proceeds) in the amount invested in cash collateral for the period* *ended February 28, 2026.* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

*ADR: American Depositary Receipt*<br>

***Fair Value Measurements***

*Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds and credit risk). Level 3 includes significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.*

*The following is a summary of the inputs used as of February 28, 2026 in valuing the Fund's investments.* 

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Assets** | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Common Stocks  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Biotechnology  | $50851622 | &nbsp;&nbsp; $— | &nbsp;&nbsp; $— | &nbsp;&nbsp; $50851622 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Health Care Distributors  | 14711162 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 14711162 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Health Care Equipment  | 49632228 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 49632228 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Health Care Services  | 3735704 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 3735704 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Health Care Supplies  | 3562716 | &nbsp;&nbsp; 898093 | &nbsp;&nbsp; — | &nbsp;&nbsp; 4460809 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Health Care Technology  | 949728 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 949728 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Life Sciences Tools & Services  | 23083114 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 23083114 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Managed Health Care  | 13956078 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 13956078 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmaceuticals  | 93931372 | &nbsp;&nbsp; 2695676 | &nbsp;&nbsp; — | &nbsp;&nbsp; 96627048 |
| Short-Term Investments  | 1127879 | &nbsp;&nbsp; — | &nbsp;&nbsp; — | &nbsp;&nbsp; 1127879 |
| **Total** | **$255541603** | &nbsp;&nbsp; **$3593769** | &nbsp;&nbsp; **$—** | &nbsp;&nbsp; **$259135372** |

---

The brand DWS represents DWS Group GmbH & Co. KGaA and any of its subsidiaries such as DWS Distributors, Inc. which offers investment products or DWS Investment Management Americas Inc. and RREEF America L.L.C. which offer advisory services.

DHWF-PH3

------

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** DEUTSCHE DWS SECURITIES TRUST

- **b. Investment Company Act file number:** 811-02021

- **c. CIK number of Registrant:** 0000088048

- **d. LEI of Registrant:** 7SL8QTS97H1HUY8AHM73

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 875 Third Avenue

  - **City:** NEW YORK

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10022-6225

  - **Telephone number:** 212-454-4500

**Item A.2. Information about the Series.**

- **a. Name of Series:** DWS Health and Wellness Fund

- **b. EDGAR series identifier (if any):** S000006103

- **c. LEI of Series:** 14DKX1AW50H1BX1XRX31

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-05-31

- **b. Date as of which information is reported:** 2026-02-28

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $259678039.33

**Total Liabilities:** $847025.02

**Net Assets:** $258831014.31

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000016787 | -1.92%               | -0.19%               | 2.01%                |
| Class ID C000016786 | -1.92%               | -0.18%               | 1.98%                |
| Class ID C000016785 | -2.00%               | -0.31%               | 1.95%                |
| Class ID C000016782 | -1.96%               | -0.21%               | 1.97%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $3633885.27              | $-8929748.57                               |
| Month 2  | $130467.77               | $-1018258.13                               |
| Month 3  | $3278512.46              | $1650109.09                                |

### Schedule of Portfolio Investments

| Name                             | Title                                       | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Alnylam Pharmaceuticals Inc      | Alnylam Pharmaceuticals Inc                 | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |      7001 | NS      | $2330772.92   | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| DWS                              | DWS Central Cash Management Government Fund | CUSIP: 25160K306<br>LEI: 5493003GD84DGSXJ7618 | Long             | STIV             | RF                | US        |   1114127 | NS      | $1114126.75   | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc       | Vertex Pharmaceuticals Inc                  | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     13581 | NS      | $6747448.23   | 2.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                | Johnson & Johnson                           | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     63685 | NS      | $15821264.55  | 6.11%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc           | UnitedHealth Group Inc                      | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |     42323 | NS      | $12412066.21  | 4.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Repligen Corp                    | Repligen Corp                               | CUSIP: 759916109<br>LEI: 54930006QJ0T5AUO1E71 | Long             | EC               | CORP              | US        |      3200 | NS      | $411936.00    | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                       | AbbVie Inc                                  | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |     52180 | NS      | $12109934.40  | 4.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc     | Thermo Fisher Scientific Inc                | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |     16298 | NS      | $8493050.78   | 3.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Agilent Technologies Inc         | Agilent Technologies Inc                    | CUSIP: 00846U101<br>LEI: QUIX8Y7A2WP0XRMW7G29 | Long             | EC               | CORP              | US        |     19806 | NS      | $2404052.28   | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| BioMarin Pharmaceutical Inc      | BioMarin Pharmaceutical Inc                 | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |     14842 | NS      | $916196.66    | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Cooper Cos Inc/The               | Cooper Cos Inc/The                          | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |     10700 | NS      | $895269.00    | 0.35%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                  | AstraZeneca PLC                             | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |     47473 | NS      | $9895746.85   | 3.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Alcon AG                         | Alcon AG                                    | CUSIP: 000000000<br>LEI: 549300LDT5AP8S0NBM78 | Long             | EC               | CORP              | CH        |     30597 | NS      | $2667446.46   | 1.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                    | Medtronic PLC                               | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |     48488 | NS      | $4735338.08   | 1.83%             |  |  |  | No            |                  1 | On Loan: No      |
| Centene Corp                     | Centene Corp                                | CUSIP: 15135B101<br>LEI: 549300Z7JJ4TQSQGT333 | Long             | EC               | CORP              | US        |     21174 | NS      | $950289.12    | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                 | Roche Holding AG                            | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |      5700 | NS      | $2695676.45   | 1.04%             |  |  |  | No            |                  2 | On Loan: No      |
| Zoetis Inc                       | Zoetis Inc                                  | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |     21656 | NS      | $2839101.60   | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp           | Boston Scientific Corp                      | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    100856 | NS      | $7750783.60   | 2.99%             |  |  |  | No            |                  1 | On Loan: No      |
| ResMed Inc                       | ResMed Inc                                  | CUSIP: 761152107<br>LEI: 529900T3QE5253CCXF22 | Long             | EC               | CORP              | US        |      9347 | NS      | $2395262.22   | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Apellis Pharmaceuticals Inc      | Apellis Pharmaceuticals Inc                 | CUSIP: 03753U106<br>LEI: 254900HS0ZFRXXSB9D42 | Long             | EC               | CORP              | US        |      3200 | NS      | $67072.00     | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                       | Biogen Inc                                  | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     11150 | NS      | $2138793.00   | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| EyePoint Inc                     | EyePoint Inc                                | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |     21900 | NS      | $384564.00    | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Insulet Corp                     | Insulet Corp                                | CUSIP: 45784P101<br>LEI: 549300TZTYD2PYN92D43 | Long             | EC               | CORP              | US        |      5332 | NS      | $1314924.52   | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Becton Dickinson & Co            | Becton Dickinson & Co                       | CUSIP: 075887109<br>LEI: ICE2EP6D98PQUILVRZ91 | Long             | EC               | CORP              | US        |     12200 | NS      | $2153056.00   | 0.83%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA Holdings Inc               | IQVIA Holdings Inc                          | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |     11400 | NS      | $2038434.00   | 0.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Veeva Systems Inc                | Veeva Systems Inc                           | CUSIP: 922475108<br>LEI: 549300YZEXPDB92M2F02 | Long             | EC               | CORP              | US        |      5218 | NS      | $949728.18    | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp                     | Stryker Corp                                | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |     19804 | NS      | $7673257.84   | 2.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                 | Novo Nordisk A/S                            | CUSIP: 670100205<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |     88210 | NS      | $3303464.50   | 1.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                     | Illumina Inc                                | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |      4691 | NS      | $630751.86    | 0.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp                      | Incyte Corp                                 | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |     12579 | NS      | $1273875.33   | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Globus Medical Inc               | Globus Medical Inc                          | CUSIP: 379577208<br>LEI: 5299003M2P4CIK0RF205 | Long             | EC               | CORP              | US        |      8100 | NS      | $773226.00    | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical Inc           | Intuitive Surgical Inc                      | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |     14659 | NS      | $7380953.09   | 2.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                        | Amgen Inc                                   | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     19793 | NS      | $7682850.88   | 2.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi SA                        | Sanofi SA                                   | CUSIP: 80105N105<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |     38050 | NS      | $1851513.00   | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Labcorp Holdings Inc             | Labcorp Holdings Inc                        | CUSIP: 504922105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3490 | NS      | $1009028.80   | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories              | Abbott Laboratories                         | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |     64801 | NS      | $7539596.35   | 2.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Privia Health Group Inc          | Privia Health Group Inc                     | CUSIP: 74276R102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     41332 | NS      | $981635.00    | 0.38%             |  |  |  | No            |                  1 | On Loan: No      |
| GE HealthCare Technologies Inc   | GE HealthCare Technologies Inc              | CUSIP: 36266G107<br>LEI: 549300OI9J7XOWZMUN85 | Long             | EC               | CORP              | US        |     19500 | NS      | $1643265.00   | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Dexcom Inc                       | Dexcom Inc                                  | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |     24708 | NS      | $1814308.44   | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                       | Pfizer Inc                                  | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |    103470 | NS      | $2860945.50   | 1.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Bio-Techne Corp                  | Bio-Techne Corp                             | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |      9200 | NS      | $542800.00    | 0.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corp        | Edwards Lifesciences Corp                   | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |     21596 | NS      | $1867406.12   | 0.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                        | Argenx SE                                   | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |      2823 | NS      | $2165015.16   | 0.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Cardinal Health Inc              | Cardinal Health Inc                         | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |     16900 | NS      | $3873987.00   | 1.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Cencora Inc                      | Cencora Inc                                 | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |     10814 | NS      | $4024321.96   | 1.55%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                       | Insmed Inc                                  | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |      8239 | NS      | $1230329.87   | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| RadNet Inc                       | RadNet Inc                                  | CUSIP: 750491102<br>LEI: 529900RECG94V2IZJ970 | Long             | EC               | CORP              | US        |     24997 | NS      | $1745040.57   | 0.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera Inc                       | Natera Inc                                  | CUSIP: 632307104<br>LEI: 529900CQ3OZ0A0VYVU59 | Long             | EC               | CORP              | US        |      4500 | NS      | $936180.00    | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc       | Neurocrine Biosciences Inc                  | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |     11537 | NS      | $1525768.25   | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| EssilorLuxottica SA              | EssilorLuxottica SA                         | CUSIP: 000000000<br>LEI: 549300M3VH1A3ER1TB49 | Long             | EC               | CORP              | FR        |      3400 | NS      | $898093.22    | 0.35%             |  |  |  | No            |                  2 | On Loan: No      |
| McKesson Corp                    | McKesson Corp                               | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |      6900 | NS      | $6812853.00   | 2.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Humana Inc                       | Humana Inc                                  | CUSIP: 444859102<br>LEI: 529900YLDW34GJAO4J06 | Long             | EC               | CORP              | US        |      3116 | NS      | $593722.64    | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                     | Danaher Corp                                | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |     28238 | NS      | $5948052.32   | 2.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc    | Regeneron Pharmaceuticals Inc               | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |      5885 | NS      | $4600127.95   | 1.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Sandoz Group AG                  | Sandoz Group AG                             | CUSIP: 799926100<br>LEI: 5493000JWK6XWFEUD320 | Long             | EC               | CORP              | CH        |      8200 | NS      | $721764.00    | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Novartis AG                      | Novartis AG                                 | CUSIP: 66987V109<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |     44700 | NS      | $7537314.00   | 2.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                   | Merck & Co Inc                              | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |     94719 | NS      | $11728106.58  | 4.53%             |  |  |  | No            |                  1 | On Loan: No      |
| West Pharmaceutical Services Inc | West Pharmaceutical Services Inc            | CUSIP: 955306105<br>LEI: 5493007NKRGM1RJQ1P16 | Long             | EC               | CORP              | US        |      5015 | NS      | $1275515.10   | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Waters Corp                      | Waters Corp                                 | CUSIP: 941848103<br>LEI: 5T547R1474YC9HOD8Q74 | Long             | EC               | CORP              | US        |      4191 | NS      | $1338521.58   | 0.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                   | Eli Lilly & Co                              | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |     31554 | NS      | $33194492.46  | 12.82%            |  |  |  | No            |                  1 | On Loan: No      |
| IDEXX Laboratories Inc           | IDEXX Laboratories Inc                      | CUSIP: 45168D104<br>LEI: OGMTXK0LUU1HKV2P0J84 | Long             | EC               | CORP              | US        |      3089 | NS      | $2028638.97   | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Baxter International Inc         | Baxter International Inc                    | CUSIP: 071813109<br>LEI: J5OIVXX3P24RJRW5CK77 | Long             | EC               | CORP              | US        |     27600 | NS      | $562212.00    | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co          | Bristol-Myers Squibb Co                     | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |     60816 | NS      | $3793093.92   | 1.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc              | Gilead Sciences Inc                         | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |     47850 | NS      | $7127257.50   | 2.75%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-03-30

**Name of Applicant:** DEUTSCHE DWS SECURITIES TRUST

**Signature:** Diane Kenneally

**Name of Signer:** Diane Kenneally

**Title:** Treasurer and Chief Financial Officer